A client recently started lamotrigine while taking valproate and now has a spreading rash, fever, and painful mouth ulcers. Which action is best?
1Apply moisturizer and take the next dose because early rashes are always benign.
2Hold lamotrigine and obtain urgent evaluation for a serious cutaneous reaction.✓ Correct answer
3Double lamotrigine to prevent withdrawal seizures before reporting the rash.
4Wait until the next routine visit unless the rash becomes itchy.
Explanation
A new rash with fever and mucosal involvement can represent a life-threatening lamotrigine reaction, with additional risk from valproate coadministration.
Quick answer Treat rash plus systemic findings as a serious lamotrigine emergency.
Why this is correct The boxed warning directs discontinuation at the first sign of rash unless clearly unrelated because benign and life-threatening rashes cannot be predicted reliably.
Easy analogy or mental picture Treat medication safety like airway triage: identify the threat, interrupt exposure, support physiology, and verify a durable response.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving reassessment and escalation.
Why the other choices are wrong Options that normalize deterioration, add interacting medication, or delay rescue leave the safety loop open.
References
1DailyMed: LAMICTAL (lamotrigine)Boxed warning for serious skin rash, risk with valproate and rapid escalation, and immediate discontinuation unless clearly unrelated
Medication safety reviewVerify the indication, current assessment, respiratory and neurologic status, interactions, authorized rescue action, and measurable follow-up.